Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors | Patent Number 11919881

US 11919881 B2
Application Number17696922
Publication NumberUS 20220315561 A1
Pendency1 year, 11 months, 24 days
Filled DateMar 17, 2022
Priority Date-
Publication DateOct 6, 2022
Expiration DateMar 16, 2042
Inventor/ApplicantsTho V. Thieu
Zhijie Liu
Guozhang Xu
Micheal D. Gaul
ExaminesMCDOWELL, BRIAN E
Art Unit1624
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.